AC01

Asset

Activates the ghrelin receptor to enhance cardiac contractility.

Stage
Phase 2
Modality
Small molecule
Target
Not known
1
Indication
2
Trials
1
Developer

Trial NCT07584967 is still running. Trial NCT07584967 started on Nov 15, 2026. clinicaltrials.gov

Indications

1

In the full profile

  • Owner and partners1
  • Trials2
  • Competitors8
  • Signals4

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets